|
|
||||||||
From the Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90024
Abstract
Most of the conventional wax D preparations from human strain Mycobacterium tuberculosis induced adjuvant arthritis (AA) and typical delayed skin reaction to purified protein derivative (PPD) in the rat. However, the tuberculin-sensitizing ability of these waxes D as judged by skin testing with PPD was variable from preparation to preparation. "Pure" wax D containing trace amounts of tuberculin-sensitizing materials has recently been extracted from a human strain M. tuberculosis H37Ra, cultivated on Sauton medium for 4 weeks. The water-soluble portion (WSP) subfractions designated as F-IA and F-IB were obtained from this pure wax D. These subfractions, which are homogeneous as revealed by Ouchterlony tests and immunoelectrophoresis, were capable of inducing AA and a delayed hypersensitivity elicited by themselves, but not by PPD. PPD and
, which were less immunogenic than F-IA and F-IB, failed to produce AA. Arthritogenicity of the parent wax D correlated more closely with the degree of skin reaction to the WSP subfractions than with the PPD skin reaction. However, after development of AA the skin reaction to F-IB decreased significantly, especially in severely diseased rats, whereas PPD positivity remained constant and strong.
Although Ouchterlony double diffusion tests with F-IA, F-IB, PPD and
revealed that an identical or partially identical component is present in all, F-IA and F-IB are peptidopolysaccharides and differ in their immunologic behavior from the tuberculoproteins, PPD and
. Evidence of two different delayed-type antigens in conventional wax D as opposed to one in pure wax D was revealed in Ouchterlony tests.
Footnotes
1 This investigation was supported by United States Public Health Service Grant GM15759 and the Kroc Foundation for the Advancement of Medical Science.
This article has been cited by other articles:
![]() |
M Higaki, T Ishihara, N Izumo, M Takatsu, and Y Mizushima Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate Ann Rheum Dis, August 1, 2005; 64(8): 1132 - 1136. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |